Using Win Odds to Improve Commit‐to‐Phase‐3 Decision‐Making in Oncology
Statistics in Medicine · 2025
DOI: 10.1002/sim.70024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Statistics in Medicine, 2025. Verfasst von Benjamin F Hartley und 5 weiteren Autor:innen. Beteiligte Einrichtung: Veramed Ltd., Twickenham, UK. Hauptthemen laut MEDLINE: Clinical Trials, Phase III as Topic, Decision Making, Medical Oncology. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: GlaxoSmithKline, GlaxoSmithKline España.
Abstract (Originalsprache)
Making good decisions about whether to commit‐to‐phase 3 clinical trials is challenging. This is especially true in oncology because the relationships between the registration endpoint, overall survival, and endpoints such as progression‐free survival and confirmed objective response are often poorly understood. We present a framework for decision‐making based on a three‐endpoint win odds. We discuss properties of the win odds and suggest that it can be interpreted, for decision‐making, as the reciprocal of an average hazard ratio for overall survival. We confirm the performance of the decision‐making method using simulation studies and a clinical trial case study. As part of this work, we describe the simulation of correlated patient‐level oncology endpoints using a multi‐state model of disease. This model can provide clinically realistic data for testing the performance of analysis methods. We conclude that the win odds can improve commit‐to‐phase‐3 decision‐making compared with other methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Veramed Ltd., Twickenham, UK.
- Statistics and Data Science Innovation Hub, GSK Research and Development, Brentford, UK.
- Oncology Statistics, GSK Research and Development, Collegeville, Pennsylvania, USA.
- Statistical Methodology, Bristol Myers Squibb, Princeton, New Jersey, USA.
ORCID-Profile: Benjamin F Hartley, Thomas Drury, Brian Di Pace, Tai-Tsang Chen, Inna Perevozskaya
Förderung
- GlaxoSmithKline
- GlaxoSmithKline España
Zitieren
APA
Hartley, B. F., Drury, T., Di Pace, B., Zhou, H., Chen, T. T., & Perevozskaya, I. (2025). Using Win Odds to Improve Commit‐to‐Phase‐3 Decision‐Making in Oncology. Statistics in Medicine. https://doi.org/10.1002/sim.70024
Vancouver
Hartley BF, Drury T, Di Pace B, Zhou H, Chen TT, Perevozskaya I. Using Win Odds to Improve Commit‐to‐Phase‐3 Decision‐Making in Oncology. Statistics in Medicine. 2025. doi:10.1002/sim.70024
BibTeX
@article{Hartley2025,
author = {Hartley, Benjamin F and Drury, Thomas and Di Pace, Brian and Zhou, Helen and Chen, Tai-Tsang and Perevozskaya, Inna},
title = {Using Win Odds to Improve Commit‐to‐Phase‐3 Decision‐Making in Oncology},
journal = {Statistics in Medicine},
year = {2025},
doi = {10.1002/sim.70024}
}
EUVIMED